CD4 and hepatocellular carcinoma: To evaluate the impact of shRNA-mediated knockdown on the HCC progression, we systematically monitored several parameters in recipient mice: survival, body weight changes, liver inflammation using biochemical parameters, and expression of ICIs on CD4 and CD8 T cells.